Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Approaching Higher Dimension Imaging Data Using Cluster-Based Hierarchical Modeling in Patients with Heart Failure Preserved Ejection Fraction.

Kobayashi Y, Tremblay-Gravel M, Boralkar KA, Li X, Nishi T, Amsallem M, Moneghetti KJ, Bouajila S, Selej M, Ozen MO, Demirci U, Ashley E, Wheeler M, Knowlton KU, Kouznetsova T, Haddad F.

Sci Rep. 2019 Jul 18;9(1):10431. doi: 10.1038/s41598-019-46873-7.

2.

Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.

Benza RL, Gomberg-Maitland M, Elliott CG, Farber HW, Foreman AJ, Frost AE, McGoon MD, Pasta DJ, Selej M, Burger CD, Frantz RP.

Chest. 2019 Aug;156(2):323-337. doi: 10.1016/j.chest.2019.02.004. Epub 2019 Feb 14.

3.

Response.

Frantz RP, Zhao C, Farber HW, Badesch DB, Elliott CG, Frost AE, McGoon MD, Mink DR, Selej M, Benza RL.

Chest. 2018 Nov;154(5):1262-1264. doi: 10.1016/j.chest.2018.07.033. No abstract available.

PMID:
30409362
4.

Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEAL.

Farber HW, Badesch DB, Benza RL, Elliott CG, Frantz RP, McGoon MD, Selej M, Zhao C, Frost AE.

J Heart Lung Transplant. 2018 Aug;37(8):948-955. doi: 10.1016/j.healun.2018.03.010. Epub 2018 Mar 17.

PMID:
29653800
5.

Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.

Frump AL, Selej M, Wood JA, Albrecht M, Yakubov B, Petrache I, Lahm T.

Am J Respir Cell Mol Biol. 2018 Jul;59(1):114-126. doi: 10.1165/rcmb.2017-0167OC.

6.

Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.

Frantz RP, Farber HW, Badesch DB, Elliott CG, Frost AE, McGoon MD, Zhao C, Mink DR, Selej M, Benza RL.

Chest. 2018 Jul;154(1):126-135. doi: 10.1016/j.chest.2018.01.009. Epub 2018 Jan 31.

7.

Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis.

Chakinala MM, Coyne DW, Benza RL, Frost AE, McGoon MD, Hartline BK, Frantz RP, Selej M, Zhao C, Mink DR, Farber HW.

J Heart Lung Transplant. 2018 Jun;37(6):696-705. doi: 10.1016/j.healun.2017.10.028. Epub 2017 Nov 6.

PMID:
29174533
8.

Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.

Talwar A, Garcia JGN, Tsai H, Moreno M, Lahm T, Zamanian RT, Machado R, Kawut SM, Selej M, Mathai S, D'Anna LH, Sahni S, Rodriquez EJ, Channick R, Fagan K, Gray M, Armstrong J, Rodriguez Lopez J, de Jesus Perez V; Pulmonary Circulation Assembly.

Am J Respir Crit Care Med. 2017 Oct 15;196(8):e32-e47. doi: 10.1164/rccm.201709-1821ST. Review.

9.

Assessing risk in pulmonary arterial hypertension: what we know, what we don't.

Benza RL, Farber HW, Selej M, Gomberg-Maitland M.

Eur Respir J. 2017 Aug 3;50(2). pii: 1701353. doi: 10.1183/13993003.01353-2017. Print 2017 Aug. No abstract available.

10.

Load Adaptability in Patients With Pulmonary Arterial Hypertension.

Amsallem M, Boulate D, Aymami M, Guihaire J, Selej M, Huo J, Denault AY, McConnell MV, Schnittger I, Fadel E, Mercier O, Zamanian RT, Haddad F.

Am J Cardiol. 2017 Sep 1;120(5):874-882. doi: 10.1016/j.amjcard.2017.05.053. Epub 2017 Jun 16.

PMID:
28705377
11.

Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models.

Amsallem M, Sweatt AJ, Aymami MC, Kuznetsova T, Selej M, Lu H, Mercier O, Fadel E, Schnittger I, McConnell MV, Rabinovitch M, Zamanian RT, Haddad F.

Circ Cardiovasc Imaging. 2017 Jun;10(6). pii: e005771. doi: 10.1161/CIRCIMAGING.116.005771.

12.

Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".

Preston IR, Roberts KE, Miller DP, Sen GP, Selej M, Benton WW, Hill NS, Farber HW.

Circulation. 2016 May 17;133(20):e662. doi: 10.1161/CIRCULATIONAHA.116.022321. No abstract available.

PMID:
27185031
13.

Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).

Preston IR, Roberts KE, Miller DP, Sen GP, Selej M, Benton WW, Hill NS, Farber HW.

Circulation. 2015 Dec 22;132(25):2403-11. doi: 10.1161/CIRCULATIONAHA.115.018435. Epub 2015 Oct 28.

14.

Development of macitentan for the treatment of pulmonary arterial hypertension.

Selej M, Romero AJ, Channick RN, Clozel M.

Ann N Y Acad Sci. 2015 Nov;1358:68-81. doi: 10.1111/nyas.12856. Epub 2015 Aug 20. Review.

PMID:
26291180
15.

Poor agreement between pulmonary capillary wedge pressure and left ventricular end-diastolic pressure in a veteran population.

Bitar A, Selej M, Bolad I, Lahm T.

PLoS One. 2014 Jan 31;9(1):e87304. doi: 10.1371/journal.pone.0087304. eCollection 2014.

16.

17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects.

Lahm T, Albrecht M, Fisher AJ, Selej M, Patel NG, Brown JA, Justice MJ, Brown MB, Van Demark M, Trulock KM, Dieudonne D, Reddy JG, Presson RG, Petrache I.

Am J Respir Crit Care Med. 2012 May 1;185(9):965-80. doi: 10.1164/rccm.201107-1293OC. Epub 2012 Mar 1.

17.

Red card for white blood cells: leukocytapheresis in sepsis.

Selej M, Lahm T.

J Surg Res. 2011 Jul;169(1):21-4. doi: 10.1016/j.jss.2010.08.038. Epub 2010 Sep 21. No abstract available.

PMID:
20888587

Supplemental Content

Support Center